cjc-1295 no dac ipamorelin perimenopause benefits timeline CJC-1295/Ipamorelin for Women: GH Therapy After 35 Sermorelin vs CJC-1295/Ipamorelin: Why Modern
Description
doi: 10.1016/j.yjmcc.2014.09.022 260
79 LiS.YangL.ZhangY.ZhangC.ShaoJ.LiuX.et al (2017)
Biochemical and haematological adverse effects are observed but are not clinically relevant
Although a few studies have been conducted in humans, the results are mixed and ultimately the drug is not approved by the US Food and Drug Administration (FDA)
Case 1: A 34-year-old lawyer in trial prep, Bay Street corridor Concern: Borderline-low B12 on bloodwork, with fatigue that crept back between oral supplement doses
